Sheena Hoadley, FNP-C

Movement Disorder/DBS Specialist, Certified Nurse Practitioner

Neurology

Accepting new patients

Call for an appointment

217-545-8000

I am a:

Request appointment

About me

Sheena Hoadley has a Masters in Science as a Family Nurse Practitioner. She specializes in Movement Disorders at SIU in the Neurology Department.

This specialty includes: DBS placement and programming, Parkinson's Disease, Essential Tremors, Tourette's, Apraxia, MSA, PSP, Lewy Body Dementia, etc.

Gender

Female

Education & training

Board Certifications

AANP

Graduate Degree

Masters of Science in Nursing- Family Nurse Practitioner, St. John's College of Nursing, Springfield, IL

Undergraduate Degree

Bachelors of Science in Nursing, St. John's College of Nursing, Springfield, IL

Specialties

Neurology

Treatments & procedures

Appointments

SIU Medicine strongly encourages all patients to verify coverage, benefits and which providers are considered in-network with their health plan. SIU Medicine has more than 300 health care providers ready to serve you and your family. SIU Medicine accepts a wide variety of governmental and non-governmental health plans to serve our community.

Request an appointment

Clinical locations

Locations

SIU Neuroscience Institute

751 N. Rutledge St. Springfield, IL 62702 Suite 3100

Get Directions

Mon - Fri: 8:00 am-4:30 pm

Clinical trials

Trial

Neuroscience Institute

324-ETD-202: A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of SAGE-324 for the Treatment of Essential Tremor

Active recruiting

The primary objective of this study is to evaluate the dose-response relationship of different doses of SAGE-324 on upper extremity tremor in a monotherapy cohort.

Trial

Neurology

A Phase 2, Double-Blind, Randomized, Placebo-Controlled, Dose-Response Study of SAGE-324 for the Treatment of Essential Tremor

Active recruiting

The primary objective of this study is to evaluate the dose-response relationship of different doses of SAGE-324 on upper extremity tremor in a monotherapy cohort.

Trial

Neurology

Roche: A Phase IIB, randomized, double-blind, placebo-controlled, multicenter study to evaluate the efficacy and safety of intravenous prasinezumab in participants with early Parkinson's disease

Active not recruiting

This study will evaluate the efficacy, safety, and pharmacokinetics of prasinezumab compared with placebo in patients with early Parkinson's disease (PD).